FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.

<h4>Objective</h4>The expression of FcγRIIIa/CD16 may render monocytes targets for activation by IgG-containing immune complexes (IC). We investigated whether FcγRIIIa/CD16 was upregulated in rheumatoid arthritis (RA), associated with TNF production in response to IC-stimulation, and if...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dawn L Cooper, Stephen G Martin, James I Robinson, Sarah L Mackie, Christopher J Charles, Jackie Nam, YEAR Consortium, John D Isaacs, Paul Emery, Ann W Morgan
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7dfe4c7e8db24f158c23d451fe0c074d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7dfe4c7e8db24f158c23d451fe0c074d
record_format dspace
spelling oai:doaj.org-article:7dfe4c7e8db24f158c23d451fe0c074d2021-11-18T07:31:12ZFcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.1932-620310.1371/journal.pone.0028918https://doaj.org/article/7dfe4c7e8db24f158c23d451fe0c074d2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22235253/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objective</h4>The expression of FcγRIIIa/CD16 may render monocytes targets for activation by IgG-containing immune complexes (IC). We investigated whether FcγRIIIa/CD16 was upregulated in rheumatoid arthritis (RA), associated with TNF production in response to IC-stimulation, and if this predicted response to methotrexate therapy.<h4>Methods</h4>FcγRIIIa/CD16 expression on CD14(low) and CD14++ monocytes was measured by flow cytometry in healthy controls and RA patients (early and long-standing disease). Intracellular TNF-staining was carried out after in vitro LPS or heat-aggregated immunoglobulin (HAG) activation. FcγRIIIa/CD16 expression pre- and post-steroid/methotrexate treatment was examined.<h4>Results</h4>Increased FcγRIIIa/CD16 expression on CD14++ monocytes in long-standing RA patients compared to controls was demonstrated (p = 0.002) with intermediate levels in early-RA patients. HAG-induced TNF-production in RA patients was correlated with the percentage of CD14++ monocytes expressing FcγRIIIa/CD16 (p<0.001). The percentage of CD14++ monocytes expressing FcγRIIIa/CD16 at baseline in early DMARD-naïve RA patients was negatively correlated with DAS28-ESR improvement 14-weeks post-methotrexate therapy (p = 0.003) and was significantly increased in EULAR non-responders compared to moderate (p = 0.01) or good responders (p = 0.003). FcγRIIIa/CD16 expression was not correlated with age, presence of systemic inflammation or autoantibody titers.<h4>Conclusion</h4>Increased FcγRIIIa/CD16 expression on CD14++ monocytes in RA may result in a cell that has increased responsiveness to IC-stimulation. This monocyte subset may contribute to non-response to methotrexate therapy.Dawn L CooperStephen G MartinJames I RobinsonSarah L MackieChristopher J CharlesJackie NamYEAR ConsortiumJohn D IsaacsPaul EmeryAnn W MorganPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 1, p e28918 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Dawn L Cooper
Stephen G Martin
James I Robinson
Sarah L Mackie
Christopher J Charles
Jackie Nam
YEAR Consortium
John D Isaacs
Paul Emery
Ann W Morgan
FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
description <h4>Objective</h4>The expression of FcγRIIIa/CD16 may render monocytes targets for activation by IgG-containing immune complexes (IC). We investigated whether FcγRIIIa/CD16 was upregulated in rheumatoid arthritis (RA), associated with TNF production in response to IC-stimulation, and if this predicted response to methotrexate therapy.<h4>Methods</h4>FcγRIIIa/CD16 expression on CD14(low) and CD14++ monocytes was measured by flow cytometry in healthy controls and RA patients (early and long-standing disease). Intracellular TNF-staining was carried out after in vitro LPS or heat-aggregated immunoglobulin (HAG) activation. FcγRIIIa/CD16 expression pre- and post-steroid/methotrexate treatment was examined.<h4>Results</h4>Increased FcγRIIIa/CD16 expression on CD14++ monocytes in long-standing RA patients compared to controls was demonstrated (p = 0.002) with intermediate levels in early-RA patients. HAG-induced TNF-production in RA patients was correlated with the percentage of CD14++ monocytes expressing FcγRIIIa/CD16 (p<0.001). The percentage of CD14++ monocytes expressing FcγRIIIa/CD16 at baseline in early DMARD-naïve RA patients was negatively correlated with DAS28-ESR improvement 14-weeks post-methotrexate therapy (p = 0.003) and was significantly increased in EULAR non-responders compared to moderate (p = 0.01) or good responders (p = 0.003). FcγRIIIa/CD16 expression was not correlated with age, presence of systemic inflammation or autoantibody titers.<h4>Conclusion</h4>Increased FcγRIIIa/CD16 expression on CD14++ monocytes in RA may result in a cell that has increased responsiveness to IC-stimulation. This monocyte subset may contribute to non-response to methotrexate therapy.
format article
author Dawn L Cooper
Stephen G Martin
James I Robinson
Sarah L Mackie
Christopher J Charles
Jackie Nam
YEAR Consortium
John D Isaacs
Paul Emery
Ann W Morgan
author_facet Dawn L Cooper
Stephen G Martin
James I Robinson
Sarah L Mackie
Christopher J Charles
Jackie Nam
YEAR Consortium
John D Isaacs
Paul Emery
Ann W Morgan
author_sort Dawn L Cooper
title FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
title_short FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
title_full FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
title_fullStr FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
title_full_unstemmed FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
title_sort fcγriiia expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated tnf production and non-response to methotrexate therapy.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/7dfe4c7e8db24f158c23d451fe0c074d
work_keys_str_mv AT dawnlcooper fcgriiiaexpressiononmonocytesinrheumatoidarthritisroleinimmunecomplexstimulatedtnfproductionandnonresponsetomethotrexatetherapy
AT stephengmartin fcgriiiaexpressiononmonocytesinrheumatoidarthritisroleinimmunecomplexstimulatedtnfproductionandnonresponsetomethotrexatetherapy
AT jamesirobinson fcgriiiaexpressiononmonocytesinrheumatoidarthritisroleinimmunecomplexstimulatedtnfproductionandnonresponsetomethotrexatetherapy
AT sarahlmackie fcgriiiaexpressiononmonocytesinrheumatoidarthritisroleinimmunecomplexstimulatedtnfproductionandnonresponsetomethotrexatetherapy
AT christopherjcharles fcgriiiaexpressiononmonocytesinrheumatoidarthritisroleinimmunecomplexstimulatedtnfproductionandnonresponsetomethotrexatetherapy
AT jackienam fcgriiiaexpressiononmonocytesinrheumatoidarthritisroleinimmunecomplexstimulatedtnfproductionandnonresponsetomethotrexatetherapy
AT yearconsortium fcgriiiaexpressiononmonocytesinrheumatoidarthritisroleinimmunecomplexstimulatedtnfproductionandnonresponsetomethotrexatetherapy
AT johndisaacs fcgriiiaexpressiononmonocytesinrheumatoidarthritisroleinimmunecomplexstimulatedtnfproductionandnonresponsetomethotrexatetherapy
AT paulemery fcgriiiaexpressiononmonocytesinrheumatoidarthritisroleinimmunecomplexstimulatedtnfproductionandnonresponsetomethotrexatetherapy
AT annwmorgan fcgriiiaexpressiononmonocytesinrheumatoidarthritisroleinimmunecomplexstimulatedtnfproductionandnonresponsetomethotrexatetherapy
_version_ 1718423353236127744